Clinical Trial Update: Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing intravenous neridronic acid for complex regional pain syndrome was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome

Drugs mentioned

• neridronic acid (neridronate)

Snippet

Sponsor: Grünenthal GmbH | Conditions: Complex Regional Pain Syndrome (CRPS) | Phase 3 | Status: TERMINATED | Results posted: 2020-08-05